Status:
NOT_YET_RECRUITING
Intertransverse Process Block to Improve Quality of Recovery and Pain Management in Adult Cardiac Surgical Patients
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Chronic Postsurgical Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the efficacy of intertransverse process block (ITPB) in improving quality of recovery and potentially preventing chronic postsurgical pain (CPSP) in adul...
Detailed Description
Introduction: The cornerstone of modern pain management in cardiac surgery lies in proactively preventing the development of chronic postsurgical pain (CPSP). This paradigm shift emphasizes pre-empti...
Eligibility Criteria
Inclusion
- adult patients aged 18 or older
- undergoing elective CABG, valve repair/replacement, or combined CABG/valve procedure via sternotomy
Exclusion
- Emergency surgery
- redo surgery
- history of chronic pain or being on chronic opioids/sedatives
- renal failure with an estimated glomerular filtration rate ≤30 ml/min (calculated by Cockcroft-Gault formula)
- re-operation within 24 hours after surgery
- intraoperative use of remifentanil
- inability to provide informed consent.
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06946290
Start Date
November 1 2025
End Date
November 1 2027
Last Update
September 3 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.